DZ3389A1 - Traitement et prevention des etats associes de resistance cardiaque a l'insuline - Google Patents
Traitement et prevention des etats associes de resistance cardiaque a l'insulineInfo
- Publication number
- DZ3389A1 DZ3389A1 DZ003389A DZ003389A DZ3389A1 DZ 3389 A1 DZ3389 A1 DZ 3389A1 DZ 003389 A DZ003389 A DZ 003389A DZ 003389 A DZ003389 A DZ 003389A DZ 3389 A1 DZ3389 A1 DZ 3389A1
- Authority
- DZ
- Algeria
- Prior art keywords
- prevention
- treatment
- insulin resistance
- associated conditions
- cardiac insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2000/002347 WO2001095906A1 (fr) | 2000-06-16 | 2000-06-16 | Traitement et prevention des etats associes a l'insulino-resistance cardiaque |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3389A1 true DZ3389A1 (fr) | 2001-12-20 |
Family
ID=9884792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ003389A DZ3389A1 (fr) | 2000-06-16 | 2000-06-16 | Traitement et prevention des etats associes de resistance cardiaque a l'insuline |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1292301A1 (fr) |
JP (1) | JP2004503499A (fr) |
CN (1) | CN1592620A (fr) |
AP (1) | AP2002002688A0 (fr) |
BG (1) | BG107384A (fr) |
BR (1) | BR0017254A (fr) |
CA (1) | CA2436116A1 (fr) |
DZ (1) | DZ3389A1 (fr) |
EA (1) | EA200300028A1 (fr) |
HU (1) | HUP0301103A2 (fr) |
IL (1) | IL153452A0 (fr) |
MX (1) | MXPA02012619A (fr) |
NO (1) | NO20026000L (fr) |
WO (1) | WO2001095906A1 (fr) |
YU (1) | YU1203A (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5902726A (en) * | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
WO1998005331A2 (fr) * | 1996-08-02 | 1998-02-12 | Ligand Pharmaceuticals Incorporated | Prevention ou traitement de diabetes non insulinodependants ou de maladies cardiovasculaires avec des modulateurs ppar |
WO1999059586A1 (fr) * | 1998-05-19 | 1999-11-25 | Regents Of The University Of California | Derives de thiazolidine et d'oxazolidine pour le traitement d'infarctus du myocarde aigus et pour l'inhibition de l'apoptose des cardiomyocytes |
MA26662A1 (fr) * | 1998-07-21 | 2004-12-20 | Smithkline Beecham Plc | Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation |
-
2000
- 2000-06-16 IL IL15345200A patent/IL153452A0/xx unknown
- 2000-06-16 CA CA002436116A patent/CA2436116A1/fr not_active Abandoned
- 2000-06-16 HU HU0301103A patent/HUP0301103A2/hu unknown
- 2000-06-16 EP EP00938933A patent/EP1292301A1/fr not_active Withdrawn
- 2000-06-16 BR BR0017254-5A patent/BR0017254A/pt not_active IP Right Cessation
- 2000-06-16 WO PCT/GB2000/002347 patent/WO2001095906A1/fr not_active Application Discontinuation
- 2000-06-16 YU YU1203A patent/YU1203A/sh unknown
- 2000-06-16 CN CNA008197679A patent/CN1592620A/zh active Pending
- 2000-06-16 MX MXPA02012619A patent/MXPA02012619A/es unknown
- 2000-06-16 JP JP2002510084A patent/JP2004503499A/ja active Pending
- 2000-06-16 DZ DZ003389A patent/DZ3389A1/fr active
- 2000-06-16 AP APAP/P/2002/002688A patent/AP2002002688A0/en unknown
- 2000-06-16 EA EA200300028A patent/EA200300028A1/ru unknown
-
2002
- 2002-12-12 BG BG107384A patent/BG107384A/bg unknown
- 2002-12-13 NO NO20026000A patent/NO20026000L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004503499A (ja) | 2004-02-05 |
CN1592620A (zh) | 2005-03-09 |
EP1292301A1 (fr) | 2003-03-19 |
NO20026000L (no) | 2003-02-11 |
CA2436116A1 (fr) | 2001-12-20 |
WO2001095906A1 (fr) | 2001-12-20 |
HUP0301103A2 (hu) | 2003-08-28 |
IL153452A0 (en) | 2003-07-06 |
AP2002002688A0 (en) | 2002-12-31 |
BR0017254A (pt) | 2004-01-06 |
NO20026000D0 (no) | 2002-12-13 |
YU1203A (sh) | 2006-05-25 |
MXPA02012619A (es) | 2003-04-10 |
BG107384A (bg) | 2003-09-30 |
EA200300028A1 (ru) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
SG93852A1 (en) | Enhanced radiopacity of peripheral and central catheter tubing | |
DE69837474D1 (de) | Antimikrobielle vorbeugung gegen und behandlung von aids und anderer infektiöser krankheiten | |
GB2368794B (en) | Prevention and treatment of amyloidogenic disease | |
HUP0201205A2 (en) | Prevention and treatment of amyloidogenic disease | |
ATE399016T1 (de) | Vorbeugung und behandlung von amyloidogener krankheit | |
FR2812197B1 (fr) | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
GB9912639D0 (en) | Improvements in and relating to treatment of respiratory conditions | |
DZ3389A1 (fr) | Traitement et prevention des etats associes de resistance cardiaque a l'insuline | |
EG22438A (en) | Disposable pul-on garment having improved fitness to body | |
GB0407486D0 (en) | Treatment and diagnosis of insulin resistant states | |
PL377110A1 (pl) | Zapobieganie i leczenie choroby Alzheimera | |
EG21720A (en) | Elastic member and disposable garment having improved fitness to body during entire use | |
AU2003231279A8 (en) | Prevention and treatment of type 2 diabetes | |
FR2774596B1 (fr) | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer | |
MA25757A1 (fr) | Traitement et prevention de conditions cardiaques associees a une resistance a l'insuline. | |
KR950022514U (ko) | 무좀방지 및 발의 건강을 도모할 수 있도록 한 개량운동화 | |
FR2797182B1 (fr) | Orthese bivalve d'extension distale des doigts | |
PL360468A1 (en) | Treatment and prevention of cardiac insulin resistance associated conditions | |
GB0030865D0 (en) | Treatment and prevention of disease | |
GB0030866D0 (en) | Treatment and prevention of disease | |
KR950022476U (ko) | 발냄새 예방 및 무좀 예방대 | |
KR950031945U (ko) | 지압 및 무좀 예방 깔창 | |
EP1152689A4 (fr) | Technique non invasive permettant de determiner le risque d'arythmie chez un patient |